DYRK1B and central nervous system cancer: In contrast, treatment with the hypoxia-mimetic cobalt chloride—previously used by Lee et al.17 in U87 glioma cells—produced a marked reduction in DYRK1B phosphotyrosine levels (Fig. 1E).